Sai Parenteral's Limited (NSE:SAIPARENT)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Branded Generic Formulations	1.27B	1.31B	914.79M
CDMO Products and Services	312.46M	187.37M	53.17M
Total	1.59B	1.50B	967.96M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
India	1.33B	1.41B	942.40M
Australia	162.70M	68.27M	16.92M
South Africa	5.32M	6.31M	4.85M
Philippines	10.59M	-	-
UAE (Dubai)	5.88M	12.28M	-
Uganda	3.33M	-	-
Nigeria	7.60M	-	-
Iraq	44.55M	-	-
Tanzania	12.48M	-	-
Others	5.78M	3.14M	3.79M
Total	1.59B	1.50B	967.96M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error